FDA Adverse Event Malfunction Summary report: N

XIENCE PROS EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 20084672 · Received August 28, 2024

Report

Report Number
2024168-2024-10127
Event Type
Malfunction
Date Received
August 28, 2024
Date of Event
August 1, 2024
Report Date
December 28, 2024
Manufacturer
ABBOTT VASCULAR
Product Code
NIQ
UDI-DI
08717648295546
PMA / PMN Number
P110019
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

MANUFACTURER'S INVESTIGATION IS STILL PENDING AT THIS TIME. RESULTS AND CONCLUSIONS WILL BE PROVIDED IN THE FINAL REPORT. THE XIENCE PROS DEVICE IS CURRENTLY NOT COMMERCIALLY AVAILABLE IN THE US; HOWEVER, IT IS SIMILAR TO A DEVICE SOLD IN THE US.

Additional Manufacturer Narrative · 0

A VISUAL INSPECTION AND FUNCTIONAL TESTING WERE PERFORMED ON THE RETURNED DEVICE. THE REPORTED MATERIAL RUPTURE WAS CONFIRMED. PRODUCTION RECORD AND CORRECTIVE AND PREVENTATIVE ACTIONS (CAPA) REVIEWS WERE PERFORMED AND REVEALED NO INDICATION OF A PRODUCT QUALITY ISSUE. ADDITIONALLY, A QUERY OF THE COMPLAINT HANDLING DATABASE FOR THE REPORTED LOT REVEALED THERE IS NO INDICATION OF A LOT SPECIFIC ISSUE. BASED ON THE REPORTED INFORMATION AND THE OBSERVATIONS FROM THE RETURNED DEVICE ANALYSIS, A DEFINITIVE CAUSE FOR THE REPORTED ISSUE COULD NOT BE DETERMINED. BASED ON THE RESULTS OF THE COMPLAINT INVESTIGATION THERE IS NO INDICATION OF A PRODUCT QUALITY ISSUE WITH RESPECT TO THE DESIGN, MANUFACTURE, OR LABELING OF THE DEVICE. D4 CORRECTION: LOT NUMBER UPDATED FROM 3091541 TO 3081041

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PROCEDURE WAS PERFORMED TO TREAT A LESION IN THE LEFT ANTERIOR DESCENDING ARTERY (LAD) WITH 3.50X18MM XIENCE PROS DRUG ELUTING STENT (DES). REPORTEDLY THE XIENCE DES WAS ADVANCED INTO THE ANATOMY; HOWEVER THE BALLOON WAS NOTED TO BE LEAKING CONTRAST AFTER BEING INFLATED FOUR TIMES TO 14 ATMOSPHERES. THE DES WAS REMOVED WITH THE STENT AND REPLACED WITH ANOTHER STENT AND THE PROCEDURE WAS COMPLETED. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1520692 XIENCE PROS EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT DELIVERY SYSTEM NIQ ABBOTT VASCULAR 1508350-18 3081041 08717648295546

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown